The article “Fine mapping QTLs in advanced interbred lines and other outbred populations,” has been accepted for publication in Mammalian Genome.
Emily will start her MPH at the Mailman School of Public Health at Columbia University in NYC this fall!
Camila will start her PhD in Neuroscience at the Sackler School for Biomedical Sciences at Tufts University in Boston this fall!
Numerous press releases and online articles accompany Amy Hart’s and Abraham Palmer’s PNAS article about amphetamine, schizophrenia and ADHD
“Liking Amphetamine Linked to Reduced Risk of Mental Disorder,” featured on The Scientist “Genetic Predisposition To Liking Amphetamine Reduces Risk Of Schizophrenia And ADHD” featured on Science Life “Genetic predisposition to liking amphetamine reduces risk of schizophrenia and ADHD” featured on
Dr. Laura Sittig’s Grant titled ” Mapping epistatic modifiers of human psychiatric risk using mouse genetics“ was funded by the National Institutes of Health & National Institute of Mental Health.
The article, “Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair” has been accepted for publication in Proceedings of the National Academy of Science (PNAS). Dr. Palmer is one of the co-authors.
The article, “Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and ADHD,” was accepted for publication in Proceedings of National Academy of Sciences (PNAS). Amy Hart (currently at UPenn) and Abraham Palmer are
Natalia’s F31 Grant titled “Integrative genetic analysis of methamphetamine’s motivational effects in mice” was funded by the National Institutes of Health & National Institute on Drug Abuse. For more information about the the F31 Ruth L. Kirschstein National Research Service Award for Individual
Dr. Abraham Palmer invited for Department of Genetics Seminar at University of Washington St. Louis. His talk was titled “Mice, rats, humans, drug abuse, psychiatric genetics and more.”
Dr. Palmer’s R21 grant titled “GWAS for goal versus sign tracking in genetically heterogeneous rats” was funded today by the National Institute on Drug Abuse. Terry Robinson and Shelley Flagel (Universty of Michigan) will be be co-investigators and Alex Gileta